Pandemic Latest News

Pfizer

Pfizer announces promising results for RSV vaccine

Barney Graham, a former scientist at the U.S. National Institute of Allergy and Infectious Diseases (NIAID), was thrilled when Pfizer announced encouraging results from an experimental vaccine that could protect against a major childhood killer. In a press release, the company said immunizing pregnant women with its vaccine against respiratory syncytial virus (RSV) protected their babies from severe …

Pfizer announces promising results for RSV vaccine Read More »

Pfizer set to test new COVID-19 pill on long-covid patients

Plans for the first test of whether Pfizer’s COVID-19 pill known as Paxlovid can alleviate Long Covid were unveiled last week, as organizers said they expect to begin recruiting 1700 volunteers in January 2023. Patient groups and researchers have long sought such a trial to study whether suppressing the SARS-CoV-2 coronavirus can reduce Long COVID’s debilitating …

Pfizer set to test new COVID-19 pill on long-covid patients Read More »

Pfizer quadruples price of COVID-19 vaccines

Pfizer’s plan to quadruple US prices for its COVID-19 vaccine next year is beyond Wall Street’s expectations and will spur its revenue for years despite weaker than anticipated demand for the new booster shot so far, analysts said. www.reuters.com/business/healthcare-pharmaceuticals/pfizer-covid-vaccine-price-hike-seen-giving-revenue-boost-years-2022-10-21/? The drugmaker, which developed and sells the vaccine with Germany’s BioNTech (22UAy.DE), said on Thursday evening …

Pfizer quadruples price of COVID-19 vaccines Read More »